Cam Gallagher - President, Interim CFO, Director at Zentalis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Interim CFO, Director
Issuer Symbol
ZNTL on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Cam Gallagher since 11 Jan 2025

Holdings reported by Cam Gallagher for Zentalis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 633,680 $7,591,486 $11.98 31 May 2024 Direct
Stock Option (Right to Buy) 192,500 01 Feb 2024 Direct Common Stock

Transactions reported by Cam Gallagher for Zentalis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.